Qrons Inc. is a biotechnology company. The Company is focused on developing biotech products, treatments, and technologies that create a platform to combat neuronal diseases. It leverages its research with developing technologies in the fields of artificial intelligence (AI), machine learning (ML), molecular biology, stem cells, and tissue engineering for deployment in the fight against neuronal diseases. The Company has developed two product candidates for treating penetrating and non-penetrating (concussion-like) traumatic brain injuries (TBIs), both integrating proprietary anti-brain inflammation synthetic hydrogel and modified mesenchymal stem cells (MSCs). Its QS100TM is an injury-specific, 3D printable, implantable MSCs-synthetic hydrogel to treat penetrating brain injuries, such as gunshot wounds, motor vehicle accidents, and falls. Its QS200TM is an injectable MSCs-synthetic hydrogel for the treatment of diffused axonal injuries commonly referred to as concussions.
More about the company